PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsNitroglycerin
Nitroglycerin
Nitro-dur, Nitroglycerin, Nitrolingual Pumpspray, Nitromist, Nitrostat, Rectiv (nitroglycerin) is a small molecule pharmaceutical. Nitroglycerin was first approved as Nitroglycerin on 1982-01-01. It is used to treat angina pectoris, diffuse esophageal spasm, eclampsia, fissure in ano, and heart failure amongst others in the USA.
Download report
Favorite
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
digestive system diseasesD004066
respiratory tract diseasesD012140
urogenital diseasesD000091642
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Nitro-dur, Nitroglycerin, Nitrolingual pumpspray, Nitromist, Nitrostat, Rectiv (discontinued: Gonitro, Minitran, Nitro, Nitro-bid, Nitroglycerin, Nitrol, Nitrolingual pumpspray, Nitrostat, Transderm-nitro, Tridil)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nitroglycerin
Tradename
Company
Number
Date
Products
RECTIVAbbVieN-021359 RX2011-06-21
1 products, RLD, RS
NITROGLYCERIN IN DEXTROSE 5%BaxterN-019970 RX1989-12-29
3 products, RLD, RS
NITROMISTEvus Health SolutionsN-021780 RX2006-11-02
1 products, RLD, RS
NITROLINGUAL PUMPSPRAYPohl-BoskampN-018705 RX1997-01-10
1 products, RLD, RS
NITRO-DURUSpharmaN-020145 RX1995-04-04
6 products, RLD, RS
NITROSTATViatrisN-021134 RX2000-05-01
3 products, RLD, RS
Show 10 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
basic dental emergency kitunapproved drug other2024-10-03
deluxe dental emergency kitunapproved drug other2024-10-03
gonitroNew Drug Application2018-06-20
minitranExport only2025-01-15
nitro-bidANDA2024-09-04
nitro-durNew Drug Application2023-05-30
nitro-timeunapproved drug other2018-10-09
nitroglycerinANDA2025-04-03
nitroglycerin in dextroseNew Drug Application2022-12-09
nitroglycerin in dextroseNew Drug Application2016-08-22
Show 9 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
heart failureEFO_0003144D006333I50
pulmonary hypertensionEFO_0001361D006976I27.20
myocardial infarctionEFO_0000612D009203I21
intraoperative complications—D007431—
angina pectorisEFO_0003913D000787I20
fissure in ano—D005401K60.2
diffuse esophageal spasmEFO_1001785D015155K22.4
eclampsia—D004461O15
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent
Expires
Flag
FDA Information
Nitroglycerin, Gonitro, Pohl Boskamp
91015922032-03-11DP
Nitroglycerin, Nitrolingual, Pohl Boskamp
78720492029-03-12DPU-2223
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
646 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SarcomaD012509————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Multiple myelomaD009101—C90.021———2
Plasma cell neoplasmsD054219——21———2
LeukemiaD007938—C95—1———1
B-cell chronic lymphocytic leukemiaD015451—C91.1—1———1
Lymphoid leukemiaD007945—C91—1———1
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNitroglycerin
INN—
Description
Nitroglycerin is a nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain. It has a role as a vasodilator agent, a nitric oxide donor, an explosive, a prodrug, a tocolytic agent, a muscle relaxant and a xenobiotic.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=[N+]([O-])OCC(CO[N+](=O)[O-])O[N+](=O)[O-]
Identifiers
PDB—
CAS-ID55-63-0
RxCUI—
ChEMBL IDCHEMBL730
ChEBI ID28787
PubChem CID4510
DrugBankDB00727
UNII ID—
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
â‚£
No data
Estimated US medical usage
Nitroglycerin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 24,632 documents
View more details
Safety
Black-box Warning
Black-box warning for: Nitro-dur, Nitroglycerin transdermal infusion system
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
10,015 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use